Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Application
Filed:
January 2, 2020
Publication date:
April 30, 2020
Applicant:
LUROMED LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Grant
Filed:
February 11, 2016
Date of Patent:
March 6, 2018
Assignee:
Luromed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Grant
Filed:
January 23, 2015
Date of Patent:
May 24, 2016
Assignee:
Luromed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Grant
Filed:
January 23, 2015
Date of Patent:
October 6, 2015
Assignee:
Luromed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Grant
Filed:
March 18, 2014
Date of Patent:
January 27, 2015
Assignee:
LuroMed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Application
Filed:
March 18, 2014
Publication date:
September 25, 2014
Applicant:
LUROMED LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are compositions comprising crosslinked hyaluronic acid gels, preferably vinyl sulfone cross-linked hyaluronic acid known as hylan B gel, for use in topical cosmetic and dermatological formulations. The hylan B gel in these formulations provides prolonged delivery of incorporated substances to the surface of the skin, to provide a hydrated film on the surface of the skin, and to provide a substantive and compatible film on the skin.
Type:
Grant
Filed:
November 28, 2008
Date of Patent:
March 25, 2014
Assignee:
LuroMed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: Disclosed are hydrophilic polymers such as polysaccharides, including hyaluronic acid of any origin, modified by reaction with epoxy-functional-silicones. Hydrophobic silicon, which contains chemically active groups covalently attach to the backbone of the hydrophilic polymer and gives these new, modified polymers the ability to dissolve hydrophobic compounds including oils, drugs, and vitamins, while maintaining the hydrophilic properties and benefits of the unmodified polymer. With respect to topical applications these polymers substantially increase the stability of formulations and provide for ease of preparation. The properties and advantages of the original polymer are maintained while other properties are augmented, namely the ability to combine with or dissolve hydrophobic and hydrophilic drugs. The products can be used alone or in combination with other substances for various applications including cosmetic, medical, and drug delivery applications. Also disclosed are methods for preparing them.
Type:
Grant
Filed:
September 28, 2009
Date of Patent:
August 21, 2012
Assignee:
LuroMed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
Abstract: The present invention provides for compositions of hyaluronic acid cross-linked with at least one other hydrophobic polymer to form a copolymer gel. The preferred composition is a formulation containing hyaluronic acid or its derivatives and a silicone base polymer with a functional group capable of reacting with the preferred cross-linker. The silicon may also be a group capable of undergoing further polymerization, or a silicone moiety adding to the hydrophobic nature of the gel. The product can be used alone or contain various other substances or covalently bound substances for numerous useful applications including cosmetic, medical, and drug delivery applications. The present invention also provides processes for preparing them.
Type:
Grant
Filed:
June 27, 2006
Date of Patent:
April 21, 2009
Assignee:
Luromed LLC
Inventors:
Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent